BERLIN, Germany, – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the first implantations worldwide of its new ICD and CRT-D series (implantable ...
MINNEAPOLIS - Medtronic, Inc. today announced market release of the CardioGuide (TM) Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and ...
RMH electrophysiologist Robert VerNooy, MD, has successfully implanted a new type of heart pacing device that helps doctors better treat patients diagnosed with heart failure. He is the first ...
ST. PAUL, MINN. - St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify™ cardiac re ...
St. Jude Medical, Inc. recently announced the U.S. launch and the first U.S. implant of its Quadra Assure MP ™ cardiac resynchronization therapy defibrillator (CRT-D). The Quadra Assura MP ™ features ...
Drs Venkat D Nagarajan, consultant, Cardiac Electrophysiologist and Dr Jamshed Dalal, director of of Cardiac Sciences at the Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai ...
MILAN, ITALY — Women are being short-changed when it comes to receiving cardiac implantable electronic devices (CIEDs), which is especially concerning because they actually have higher survival rates ...
Please provide your email address to receive an email when new articles are posted on . Patients with HF who received an implantable cardioverter defibrillator or cardiac resynchronization ...
Effective immediately, the American College of Cardiology is offering the EP Device Implant Registry, which will include data on ICD and CRT-D procedures previously captured in the NCDR ICD Registry ...
Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a large new study ...
Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective. As described in a June notice made ...
Medtronic announced Friday that FDA has approved the the first MR-conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure in the U.S. The Medtronic ...